1,2-dichloroethane increases expression ISO RGD:1623805 6480464 ethylene dichloride results in increased expression of NRBP2 mRNA CTD PMID:28189721 , PMID:28960355 17alpha-ethynylestradiol affects expression ISO RGD:1623805 6480464 Ethinyl Estradiol affects the expression of NRBP2 mRNA CTD PMID:17555576 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NRBP2 mRNA CTD PMID:21215274 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of NRBP2 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1623805 6480464 Tetrachlorodibenzodioxin results in decreased expression of NRBP2 mRNA CTD PMID:26290441 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1623805 6480464 Tetrachlorodibenzodioxin affects the expression of NRBP2 mRNA CTD PMID:21570461 , PMID:26377647 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1623805 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of NRBP2 mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1351329 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NRBP2 mRNA CTD PMID:28628672 4-hydroxyphenyl retinamide increases expression ISO RGD:1623805 6480464 Fenretinide results in increased expression of NRBP2 mRNA CTD PMID:28973697 acrylamide decreases expression ISO RGD:1351329 6480464 Acrylamide results in decreased expression of NRBP2 mRNA CTD PMID:32763439 aflatoxin B1 affects expression ISO RGD:1351329 6480464 Aflatoxin B1 affects the expression of NRBP2 protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO RGD:1351329 6480464 Aflatoxin B1 results in decreased expression of NRBP2 mRNA CTD PMID:22100608 aldehydo-D-glucose decreases expression ISO RGD:1623805 6480464 Glucose results in decreased expression of NRBP2 mRNA CTD PMID:33448797 aldehydo-D-glucose multiple interactions ISO RGD:1623805 6480464 fucoxanthin inhibits the reaction [Glucose results in decreased expression of NRBP2 mRNA] CTD PMID:33448797 antirheumatic drug increases expression ISO RGD:1351329 6480464 Antirheumatic Agents results in increased expression of NRBP2 mRNA CTD PMID:24449571 aristolochic acid decreases expression ISO RGD:1351329 6480464 aristolochic acid I results in decreased expression of NRBP2 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:1623805 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of NRBP2 mRNA CTD PMID:23650126 arsane increases methylation ISO RGD:1351329 6480464 Arsenic results in increased methylation of NRBP2 promoter CTD PMID:21291286 arsenic atom increases methylation ISO RGD:1351329 6480464 Arsenic results in increased methylation of NRBP2 promoter CTD PMID:21291286 benzo[a]pyrene increases expression ISO RGD:1351329 6480464 Benzo(a)pyrene results in increased expression of NRBP2 mRNA CTD PMID:20106945 , PMID:21632981 benzo[a]pyrene affects methylation ISO RGD:1351329 6480464 Benzo(a)pyrene affects the methylation of NRBP2 intron CTD PMID:30157460 benzo[a]pyrene decreases methylation ISO RGD:1351329 6480464 Benzo(a)pyrene results in decreased methylation of NRBP2 5' UTR CTD PMID:27901495 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1623805 6480464 Diethylhexyl Phthalate results in decreased expression of NRBP2 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1623805 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of NRBP2 mRNA] CTD PMID:19850644 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of NRBP2 mRNA CTD PMID:25181051 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of NRBP2 mRNA CTD PMID:30816183 , PMID:33296240 bisphenol F multiple interactions ISO RGD:1351329 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NRBP2 mRNA CTD PMID:28628672 buspirone increases expression EXP 6480464 Buspirone results in increased expression of NRBP2 mRNA CTD PMID:24136188 carbon nanotube decreases expression ISO RGD:1623805 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube increases expression ISO RGD:1623805 6480464 Nanotubes more ... CTD PMID:25620056 cerium trichloride increases expression ISO RGD:1623805 6480464 cerous chloride results in increased expression of NRBP2 mRNA CTD PMID:23573234 chlordecone increases expression ISO RGD:1623805 6480464 Chlordecone results in increased expression of NRBP2 mRNA CTD PMID:33711761 choline multiple interactions ISO RGD:1623805 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NRBP2 gene CTD PMID:20938992 chrysene increases expression ISO RGD:1623805 6480464 chrysene results in increased expression of NRBP2 mRNA CTD PMID:26377693 cisplatin multiple interactions ISO RGD:1351329 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of NRBP2 mRNA CTD PMID:27392435 clofibrate multiple interactions ISO RGD:1623805 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of NRBP2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NRBP2 mRNA] CTD PMID:17585979 clofibrate decreases expression ISO RGD:1623805 6480464 Clofibrate results in decreased expression of NRBP2 mRNA CTD PMID:17585979 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of NRBP2 mRNA CTD PMID:24386269 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of NRBP2 mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO RGD:1351329 6480464 Cyclosporine results in decreased expression of NRBP2 mRNA CTD PMID:20106945 , PMID:25562108 cyclosporin A decreases methylation ISO RGD:1351329 6480464 Cyclosporine results in decreased methylation of NRBP2 promoter CTD PMID:27989131 D-glucose multiple interactions ISO RGD:1623805 6480464 fucoxanthin inhibits the reaction [Glucose results in decreased expression of NRBP2 mRNA] CTD PMID:33448797 D-glucose decreases expression ISO RGD:1623805 6480464 Glucose results in decreased expression of NRBP2 mRNA CTD PMID:33448797 dexamethasone increases expression ISO RGD:1623805 6480464 Dexamethasone results in increased expression of NRBP2 mRNA CTD PMID:22733784 dexamethasone multiple interactions ISO RGD:1351329 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NRBP2 mRNA CTD PMID:28628672 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of NRBP2 mRNA CTD PMID:21266533 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of NRBP2 mRNA CTD PMID:21266533 dichloroacetic acid decreases expression ISO RGD:1623805 6480464 Dichloroacetic Acid results in decreased expression of NRBP2 mRNA CTD PMID:28962523 dioxygen multiple interactions ISO RGD:1623805 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NRBP2 mRNA CTD PMID:30529165 doxorubicin decreases expression ISO RGD:1351329 6480464 Doxorubicin results in decreased expression of NRBP2 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of NRBP2 mRNA CTD PMID:29391264 ethanol affects splicing ISO RGD:1623805 6480464 Ethanol affects the splicing of NRBP2 mRNA CTD PMID:30319688 fenthion decreases expression ISO RGD:1623805 6480464 Fenthion results in decreased expression of NRBP2 mRNA CTD PMID:34813904 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of NRBP2 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1623805 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NRBP2 gene CTD PMID:20938992 fucoxanthin multiple interactions ISO RGD:1623805 6480464 fucoxanthin inhibits the reaction [Glucose results in decreased expression of NRBP2 mRNA] CTD PMID:33448797 furan decreases expression ISO RGD:1623805 6480464 furan results in decreased expression of NRBP2 mRNA CTD PMID:24183702 furan decreases expression EXP 6480464 furan results in decreased expression of NRBP2 mRNA CTD PMID:25539665 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of NRBP2 mRNA CTD PMID:33387578 glucose decreases expression ISO RGD:1623805 6480464 Glucose results in decreased expression of NRBP2 mRNA CTD PMID:33448797 glucose multiple interactions ISO RGD:1623805 6480464 fucoxanthin inhibits the reaction [Glucose results in decreased expression of NRBP2 mRNA] CTD PMID:33448797 hydroquinone increases expression ISO RGD:1351329 6480464 hydroquinone results in increased expression of NRBP2 mRNA CTD PMID:29221148 indometacin multiple interactions ISO RGD:1351329 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NRBP2 mRNA CTD PMID:28628672 L-methionine multiple interactions ISO RGD:1623805 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NRBP2 gene CTD PMID:20938992 leflunomide decreases expression ISO RGD:1351329 6480464 leflunomide results in decreased expression of NRBP2 mRNA CTD PMID:28988120 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of NRBP2 mRNA CTD PMID:24136188 levofloxacin increases expression EXP 6480464 Levofloxacin results in increased expression of NRBP2 mRNA CTD PMID:24136188 methamphetamine increases expression ISO RGD:1623805 6480464 Methamphetamine results in increased expression of NRBP2 mRNA CTD PMID:26307267 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of NRBP2 mRNA CTD PMID:22484513 methidathion increases expression ISO RGD:1623805 6480464 methidathion results in increased expression of NRBP2 mRNA CTD PMID:34813904 methoxyacetic acid affects expression EXP 6480464 methoxyacetic acid affects the expression of NRBP2 mRNA CTD PMID:20864626 methylmercury chloride decreases expression ISO RGD:1351329 6480464 methylmercuric chloride results in decreased expression of NRBP2 mRNA CTD PMID:28001369 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of NRBP2 mRNA CTD PMID:24136188 Nor-9-carboxy-delta9-THC multiple interactions ISO RGD:1351329 6480464 [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of NRBP2 gene CTD PMID:30521419 paracetamol multiple interactions ISO RGD:1623805 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of NRBP2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NRBP2 mRNA] CTD PMID:17585979 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of NRBP2 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:1351329 6480464 Acetaminophen results in decreased expression of NRBP2 mRNA CTD PMID:26690555 paracetamol affects expression ISO RGD:1623805 6480464 Acetaminophen affects the expression of NRBP2 mRNA CTD PMID:17562736 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of NRBP2 mRNA CTD PMID:32680482 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1351329 6480464 perfluorooctane sulfonic acid results in decreased expression of NRBP2 mRNA CTD PMID:27153767 piperonyl butoxide decreases expression EXP 6480464 Piperonyl Butoxide results in decreased expression of NRBP2 mRNA CTD PMID:22484513 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1623805 6480464 Pregnenolone Carbonitrile results in increased expression of NRBP2 mRNA CTD PMID:28903501 propiconazole decreases expression ISO RGD:1623805 6480464 propiconazole results in decreased expression of NRBP2 mRNA CTD PMID:21278054 rotenone increases expression EXP 6480464 Rotenone results in increased expression of NRBP2 mRNA CTD PMID:28374803 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of NRBP2 mRNA CTD PMID:22110744 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of NRBP2 mRNA CTD PMID:25993096 tamoxifen affects expression ISO RGD:1623805 6480464 Tamoxifen affects the expression of NRBP2 mRNA CTD PMID:17555576 tetraphene decreases expression ISO RGD:1623805 6480464 benz(a)anthracene results in decreased expression of NRBP2 mRNA CTD PMID:26377693 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of NRBP2 mRNA CTD PMID:23411599 , PMID:34492290 valproic acid decreases expression ISO RGD:1351329 6480464 Valproic Acid results in decreased expression of NRBP2 mRNA CTD PMID:29154799